158 related articles for article (PubMed ID: 869958)
1. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
Laitinen O; Leirisalo M; Skylv G
Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
[TBL] [Abstract][Full Text] [Related]
2. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
Leirisalo M; Laitinen O; Tiilikainen A
J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
[TBL] [Abstract][Full Text] [Related]
3. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27.
Leirisalo M; Skylv G; Kousa M; Voipio-Pulkki LM; Suoranta H; Nissilä M; Hvidman L; Nielsen ED; Svejgaard A; Tilikainen A; Laitinen O
Arthritis Rheum; 1982 Mar; 25(3):249-59. PubMed ID: 6978139
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection.
Nickerson CL; Luthra HS; Savarirayan S; David CS
Hum Immunol; 1990 Aug; 28(4):382-96. PubMed ID: 2391253
[TBL] [Abstract][Full Text] [Related]
5. Family study of Reiter's disease and HLA B27 distribution.
Kousa M; Lassus A; Karvonen J; Tillikainen A; Aho K
J Rheumatol; 1977; 4(1):95-102. PubMed ID: 886557
[TBL] [Abstract][Full Text] [Related]
6. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
Sheldon PJ; Mair NS; Fox E
Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
[TBL] [Abstract][Full Text] [Related]
7. Yersinia antibodies in inflammatory joint diseases.
Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
[TBL] [Abstract][Full Text] [Related]
8. The HLA system and the arthropathies associated with psoriasis.
Eastmond CJ; Woodrow JC
Ann Rheum Dis; 1977 Apr; 36(2):112-20. PubMed ID: 857739
[TBL] [Abstract][Full Text] [Related]
9. Reiter's disease and the histocompatibility antigen, HL-A 27.
Zachariae H; Friis J; Graudal H; Hjortshøj A; Kissmeyer-Nielsen F; Svejgaard A; Svejgaard E; Zachariae E
Scand J Rheumatol; 1975; 4(1):13-5. PubMed ID: 50618
[TBL] [Abstract][Full Text] [Related]
10. [Yersinia enterocolitica, ankylosing spondylitis and HL-A B27].
Kluin-Nelemans JC; Meuwissen OJ
Ned Tijdschr Geneeskd; 1977 Apr; 121(15):629-31. PubMed ID: 854105
[No Abstract] [Full Text] [Related]
11. Follow-up study of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis.
Leirisalo-Repo M; Skylv G; Kousa M
Clin Rheumatol; 1987 Sep; 6 Suppl 2():73-82. PubMed ID: 3500825
[TBL] [Abstract][Full Text] [Related]
12. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
Repo H; Leirisalo M; Tiilikainen A; Laitinen O
Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
[TBL] [Abstract][Full Text] [Related]
13. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
Kobayashi S; Ogasawara M; Maeda K; Yu DT
J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
[TBL] [Abstract][Full Text] [Related]
15. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
Dequeker J; Decock T; Walravens M; Van de Putte I
J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
[TBL] [Abstract][Full Text] [Related]
17. HL-A antigens in Behcet's disease.
O'Duffy JD; Taswell HF; Elveback LR
J Rheumatol; 1976 Mar; 3(1):1-3. PubMed ID: 1271386
[TBL] [Abstract][Full Text] [Related]
18. Letter: HLA B27 in blacks with ankylosing spondylitis or Reiter's disease.
Good AE; Kawanishi H; Schultz JS
N Engl J Med; 1976 Jan; 294(3):166-7. PubMed ID: 1244519
[No Abstract] [Full Text] [Related]
19. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
[TBL] [Abstract][Full Text] [Related]
20. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
Nickerson CL; Hogen KL; Luthra HS; David CS
Scand J Rheumatol Suppl; 1990; 87():85-90; discussion 90. PubMed ID: 2259892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
